DJ Biogen Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ shed 1.27% to $171.59 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.03% to 6,915.61 and the Dow Jones Industrial Average falling 0.58% to 49,098.71.
The stock's fall snapped a three-day winning streak.
Biogen Inc. closed 9.78% below its 52-week high of $190.20, which the company achieved on January 9th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.76% to $220.14, Pfizer Inc. $(PFE)$ fell 0.08% to $25.65, and AbbVie Inc. $(ABBV)$ rose 0.53% to $219.26.
Trading volume (1.1 M) remained 936,087 below its 50-day average volume of 2.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 23, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 23, 2026 17:01 ET (22:01 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments